Medicare
Last year unjustified price increases for nine drugs cost US healthcare $1.67 billion, Humira accounted for $1.4 billion
According to this year’s report, last year the US health system spent an extra $1.67 billion on price increases for nine drugs that were not supported by clinical evidence. Humira led this year’s list at $1.4 billion, accounting for 84% of US unjustified drug price increases in 2020. Humira aside, the more modest price increases…
Read MoreResponse to OHS primary care capitation defense
Today, the CT Health Policy Project responded to a letter from the Office of Health Strategy regarding concerns from 25 independent consumer advocates, providers, and organizations. OHS’s response to our offer to work together to improve the health of every Connecticut resident is very welcome. In that spirit, the letter clarifies a few misunderstandings of…
Read MoreCTNJ op-ed: It’s a miracle — Under new agreement, Medicare will negotiate drug prices
Democrats in Washington have negotiated a deal to allow Medicare to negotiate prices with drug companies. Americans pay 2.56 times higher drug prices than residents of other developed countries. It has always been embarrassing that federal law prohibits Medicare drug price negotiation and the FDA can’t consider costs in drug approvals. The US is the…
Read MoreNew Cost Cap Steering Committee is industry-driven
The first meeting of the new Steering Committee to guide the Office of Health Strategy’s (OHS) plan to cap healthcare cost growth was uncharacteristically quiet. The meeting started with public comment from the Universal Healthcare Foundation of CT that the committee membership is “not balanced”, includes mainly members with “deep vested business interests”, and lacks…
Read MoreCTNJ op-ed: Patient-centered or doctor-centered? Primary care planning is off track
Several state agencies and their committees are planning to expand primary care in Connecticut – that’s a good thing. But it’s being driven by primary care doctors and their needs rather than patients. Read more
Read MoreConnecticut hospital systems vary in reducing low-value care
A new report published in JAMA Internal Medicine on low-value care provided to Medicare beneficiaries at the health system level offers actionable tools to improve effective care on the ground. Healthcare services that provide little or no health benefit, may harm patients, increase costs, and waste resources are low-value. Examples include prostate specific antigen testing…
Read MoreCTNJ: OP-ED | Legislators Hear How RI Saved 2 Hospitals From Private Equity, Other Solutions to High Insurance Premiums
On Friday, in a forum sponsored by state Rep. Kerry Wood, six national and local experts gave legislators specific policy tools to help with health care market consolidation and rising drug prices that are driving up health insurance premiums. Legislators also got specific tools used by Rhode Island to avoid private equity abuses experienced in…
Read MoreCTNJ OP-ED | Congress Wants to Lower Drug Prices to Fund Important Priorities
Economists argue that rising healthcare costs crowd out resources for other societal priorities such as education, infrastructure, climate change, and housing. It makes sense in theory but, until lately, it seemed a bit abstract. But right now, Congress and the administration are making the point in very real terms. Policymakers want to make big investments…
Read MoreNew healthy aging data report finds CT growing older in every community
Connecticut is the 7th oldest state in the country, according to a new analysis by UConn Boston and Tufts Health Plan Foundation, with 23% of state residents over age 60. The challenges of aging are not evenly spread across the state. Visit the site to see how seniors in your town/city compare to the state…
Read MoreOHS committee considering dumbing down successful PCMH standards
Among other troubling plans, the Office of Health Strategy’s Primary Care Subgroup is considering four options to certify high-performing primary care practices for higher levels of reimbursement. The committee is deciding how to double spending on primary care while simultaneously capping healthcare cost growth. At their meeting this week, the committee of mainly primary care…
Read More